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Abstract
Background: The Magel2 gene is most highly expressed in the suprachiasmatic nucleus of the hypothalamus,
where its expression cycles in a circadian pattern comparable to that of clock-controlled genes. Mice lacking the
Magel2 gene have hypothalamic dysfunction, including circadian defects that include reduced and fragmented
total activity, excessive activity during the subjective day, but they have a normal circadian period. Magel2 is a
member of the MAGE family of proteins that have various roles in cellular function, but the specific function of
Magel2 is unknown.
Methods: We used a variety of cell-based assays to determine whether Magel2 modifies the properties of core
circadian rhythm proteins.
Results: Magel2 represses the activity of the Clock:Bmal1 heterodimer in a Per2-luciferase assay. Magel2 interacts
with Bmal1 and with Per2 as measured by co-immunoprecipitation in co-transfected cells, and exhibits a
subcellular distribution consistent with these interactions when visualized by immunofluorescence. As well, Magel2
induces the redistribution of the subcellular localization of Clock towards the cytoplasm, in contrast to the nucleus-
directed effect of Bmal1 on Clock subcellular localization.
Conclusion: Consistent with the blunted circadian rhythm observed in Magel2-null mice, these data suggest that
Magel2 normally promotes negative feedback regulation of the cellular circadian cycle, through interactions with
key core circadian rhythm proteins.
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Introduction
Prader-Willi syndrome (PWS) is a genetic neurodevelop-
mental disorder featuring neonatal failure to thrive, hyper-
phagia leading to obesity, growth hormone deficiency, and
other findings [1-3]. About 80% of affected individuals suf-
fer from sleep-wake cycle disturbances, typically character-
ized as excessive daytime sleepiness, with night or early
morning waking [4]. These clinical findings implicate
hypothalamic dysfunction in PWS, but the pathophysiol-
ogy of this disorder remains poorly understood, in part
because at least five genes are inactivated in typical
affected individuals. We identified MAGEL2, a member of
the necdin/MAGE protein family, as a candidate gene for
some features of PWS [2,3]. In adult mice, Magel2 expres-
sion is restricted to the nervous system, with the majority
of Magel2-positive neurons located in the hypothalamus
[5]. Within the hypothalamus, Magel2 is primarily
expressed in the paraventricular nucleus, supraoptic
nucleus, and in the suprachiasmatic nucleus (SCN), which
is the circadian rhythm generating center of the brain [6].
Within the SCN, Magel2-positive neurons overlap with
neurons expressing arginine vasopressin in the dorsal
SCN, which modulate circadian rhythm and conduct cir-
cadian output signals to target organs and other areas of
the brain.
Using running wheel activity monitoring, we previously
found that gene-targeted Magel2-deficient mice had
reduced and more fragmented total activity, with a
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activity during the subjective day compared to wild-type
mice, but had a normal circadian period. We also discov-
ered progressive infertility in these mice, with irregular
estrus cycles in female mice that mimic those seen in
other circadian mutant mice [8,9]. These and other find-
ings of endocrine disruption [10] support a role for loss
of MAGEL2 in the hypothalamic disruption observed in
PWS. However, the manner in which Magel2 normally
contributes to the maintenance of circadian rhythm in
hypothalamic neurons has not been explored.
The expression of many genes in the SCN follows a cir-
cadian cycle, such that different groups of genes have
peaks of high expression at specific times of the 24-hour
day. Within each cell, a roughly 24-hour cycle of gene
expression is driven by a transcription translation feedback
loop that results in the periodic transcription of a set of
genes, the clock-controlled genes. This loop is driven by
the activity of a heterodimer of two bHLH (basic helix-
loop-helix) transcription factors, Clock and Bmal1. Clock
and Bmal1 heterodimerize to activate clock-controlled
genes, typically acting through E-box elements in the tar-
get promoters [11]. These target genes include those of
the Period (Per) and Cryptochrome (Cry) families. The
proteins encoded by the Per and Cry genes accumulate,
then heterodimerize and feedback to inhibit the activity of
Clock:Bmal1 and thus their own transcription, which
reaches a nadir by the end of circadian night [12,13]. A
delay in this negative feedback loop is introduced by the
regulated post-translational modification and E3-ligase-
mediated degradation of Cry and Per in the cytoplasm
[14,15].
In a thorough examination of gene expression in the
SCN of mice entrained to a 12 hour light-12 hour cycle
dark, then released into darkness, 337 genes were found to
have circadian expression in the SCN [6]. Among these,
Magel2 was one of the most highly circadian genes identi-
fied, with Per2 also identified as expected. The peak of
Magel2 expression is at circadian time (CT) 12-14, in the
late light period, and the trough at CT24, a pattern that
was verified by in situ hybridization in additional mouse
SCN samples [6,7]. This expression peak is about 2 hours
d e l a y e df r o mt h a to fPer2, which has peak expression
around CT10, whereas the peak of Clock:Bmal1 activity is
around CT8 [16]. The circadian pattern of expression and
the timing of peak expression suggest that, like Per2,
Magel2 is a clock-controlled gene, although this has not
been directly demonstrated.
The physiological mechanism of action of Magel2 in the
maintenance of circadian rhythm is unknown. Magel2 is
one of the lesser studied of a family of “MAGE” proteins,
which contain a melanoma antigen (MAGE) homology
domain that contributes to protein-protein interactions
[17,18]. MAGE proteins can interact with transcription
factors and nuclear receptors, with downstream effects on
gene activity. Notably, previous studies have demonstrated
physical interactions between the MAGE protein necdin
and proteins of the bHLH-PAS (Per/Arnt/Sim) family of
transcription factors [19,20]. These necdin-interacting pro-
teins include Hif1a, Arnt (Hif1b), Arnt2, and Bmal1, with
the interactions occurring through the bHLH domain of
each of the bHLH-PAS transcription factors. The hetero-
dimers Arnt:Hif1a and Arnt2:Sim1 activate transcription
by binding upstream response elements in target genes,
and co-expression of necdin represses this activity [19,20].
Necdin also interacts with SIRT1, which regulates the
amplitude of clock-controlled gene expression through
deacetylation of Per2, Bmal1, and associated histones
[21-23].
MAGE proteins also modulate the activity of E3 ubiqui-
tin ligases through their interactions with RING domain
proteins, forming complexes that regulate protein degra-
dation. A multitude of such interactions have been uncov-
ered through interaction screens and directed assays, and
the large number of MAGE proteins (~60) and of RING
domain proteins (hundreds) makes additional undiscov-
ered interactions likely [18,24-28]. MAGE proteins modu-
late protein stability by recruiting E2 conjugating enzymes
to specific E3 substrate complexes. Candidate target pro-
teins for MAGE/RING mediated degradation include p53
(MAGE/TRIM28) [26], AATF/Che1 (MAGED1/RING
protein) [29] Hif1a (necdin/RING protein, possibly Rbx1/
Roc1) [19,30], EID1 (necdin/RING protein) [31], and Fez1
(necdin or Magel2/RING protein), [32]. Many of the pro-
teins targeted by E3 ligases are regulated by sequestration
and proteosomal degradation in the cytoplasm, in some
cases through their interactions with MAGE proteins
[26,27,29,31,33]. With respect to core circadian proteins,
the Skp1-Cullin-F box E3 ligase-associated proteins are
implicated in the targeted degradation of Cry and Per pro-
teins [14,15], but the RING protein associated with the
complex, namely Rbx1/Roc1 [30], has not been yet been
associated with a specific MAGE protein.
Lastly, mice deficient for the MAGE gene Maged1 exhi-
bit a short period circadian phenotype, but Maged1 itself
is not circadian in its expression [34]. It was proposed that
Maged1 normally cooperates with the orphan nuclear
receptor Rora to modulate the expression of circadian
genes, including Bmal1. Altogether, these results suggest
multiple ways in which MAGE proteins could act in a
feedback loops that regulate the rhythmic activity of circa-
dian proteins.
The circadian profile of Magel2, the participation of
MAGE proteins in the regulation of unstable proteins
and transcription factors, and the circadian phenotype in
the Magel2-null mice, together strongly suggest that
Magel2 is involved in regulation of circadian rhythm. We
therefore hypothesized that Magel2 could interact with
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acting to regulate either the transcriptional function or
the subcellular localization of these proteins. We exam-
ined the effect of Magel2 on circadian rhythm proteins,
in a heterologous expression system in tissue culture
cells. We found that indeed Magel2 represses Clock:
Bmal1 mediated transcription, and that Magel2 can inter-
act with Per2 and with Bmal1. Interestingly, Magel2 co-
localizes with Clock and Bmal1 in the cytoplasm, and
with Per2 in the cytoplasm and nucleus, and Magel2
influences the subcellular localization of Bmal1 and
Clock. These results lend support to the importance of
Magel2 in the regulation of circadian proteins, as sug-




The previously described epitope-tagged expression plas-
mid for murine Magel2 (pcDNA4HisMaxXpressMagel2)
is referred to as pXpress-Magel2 [32]. Expression con-
structs for murine Per2 (pcDNA3.1Per2V5His, pPer2-V5)
and Cry1 (pcDNA3.1Cry1V5His, pV5-Cry) were obtained
from Dr. J. Takahashi at Northwestern University [35]. An
expression plasmid for murine Bmal1 (pcDNA3HABmal1,
pHA-Bmal1) and two murine Clock constructs (pcDNA3-
HAClock, pHA-Clock and pcDNA3.1MycClock, pMyc-
Clock) were obtained from Dr. M. Antoch at the Roswell
Park Cancer Institute [36,37]. The pGL3-E2 box circadian
enhancer plasmid, mPer2:luc, includes the noncanonical
circadian enhancer E-box from Per2 and was from Dr. J.
Takahashi [38]. A pRL-TK Renilla luciferase vector was
used as an internal control reporter [31].
Antibodies
Primary antibodies used for immunoblotting and immu-
nofluorescence were: mouse monoclonal anti-Xpress and
anti-V5 (Invitrogen, Carlsbad, CA), mouse monoclonal
anti-HA (Sigma-Aldrich, Oakville, ON), rabbit polyclonal
anti-HA (Santa Cruz Biotechnologies, Santa Cruz, CA),
rabbit polyclonal anti-Myc (Sigma-Aldrich), mouse mono-
clonal anti-myc (Sigma), and rabbit polyclonal anti-V5
(Millipore, Billerica, MA). Secondary antibodies used for
immunoblots were sheep anti-mouse and goat anti-rabbit
IgG (GE Healthcare). Secondary antibodies used for
immunofluorescence were goat anti-mouse Alexa Fluor
488 and 594 and goat anti-rabbit Alexa Fluor 488 and 594
(Invitrogen).
Cell culture and transient transfection
NIH3T3 cell lines were cultured in Dulbecco’s modified
Eagle’sm e d i u m( D M E M )s u p p l e m e n t e dw i t h1 0 %c a l f
serum (CS) (Invitrogen). HEK293 cell lines were main-
tained in DMEM supplemented with 10% fetal bovine
serum. NIH3T3 or HEK293 cells were plated 18 to 24
hours prior to transfection, then transfected using Attrac-
tene Transfection Reagent (Qiagen, Mississauga, ON)
according to the manufacturer’s instructions. For the
luciferase assays, a total of 0.4 μg of appropriate combi-
nation of plasmid DNA and 5 ng of pRL-TK Renilla luci-
ferase control plasmid were diluted in 60 μLo fD M E M .
One μL of Attractene was added to the diluted DNA and
mixed by light tapping. When required, vector plasmids
without cDNA inserts were co-transfected in order to
keep the total amount of plasmid constant across all
transfections. The resulting mixtures were incubated for
15 min. at room temperature. The appropriate plasmid
combinations were added drop-wise onto the cells and
the plates swirled to evenly distribute the mixture. The
plates were then incubated at 37°C and 5% CO2 for 18 to
24 hours before recovering cell lysates for immunoblot-
ting or luciferase assays. Alternatively, cells were plated
into 6 well dishes with coverslips, transfected, then the
coverslips were processed for immunohistochemistry.
Protein half-life was measured by treating cells with 100
μg/ml cycloheximide (Sigma-Aldrich). Cell lysates were
then collected and immunoblotting was used to detect
and quantify protein levels, which were then plotted ver-
sus the collection times. Co-immunoprecipitations, SDS-
polyacrylamide gel electrophoresis and immunoblotting
were used to separate and visualize proteins, essentially
as described [31]. Decay curves were fit to the data
points, and the half-life of each recombinant protein
determined using the equation of the line. Immunoblot
analysis was performed using Kodak Image Station Soft-
ware and protein quantities were calculated as a ratio of
the pixel intensity from the protein of interest to that of
g-tubulin.
Dual luciferase assays
Dual luciferase assays were performed using the Dual
Luciferase Reporter System kit (Promega Corporation,
Madison, WI). Relative luciferase activity was assayed as
previously described using a TD-20/20 Luminometer
(Turner Designs, Sunnyvale, CA) and normalized to an
internal Renilla luciferase control [31].
Immunofluorescence
Cells were plated on coverslips in a 6-well plate and
transfected. The next day, the cells were washed with
PBS, fixed in 4% paraformaldehyde, then washed three
times in PBS with 0.05% Triton-X (PBSX). Nonspecific
antibody binding was blocked with 2% Blocking Reagent
(Roche Applied Science, Laval, QC) for 15 min. The cov-
erslips were then incubated with the appropriate primary
antibodies for 1 hour at room temperature, washed twice
with PBSX, incubated for 1 hour with the appropriate
fluorescently tagged secondary antibody, washed twice in
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the coverslips were washed again in PBSX, then were
mounted on glass slides. Triple fluorescence images were
acquired then processed in ImageJ64 (imagej.nih.gov/ij)
and analyzed using the PlotProfile function for nuclear-
cytoplasmic subcellular localization and signal overlap.
Linescan diagrams from individual representative co-
transfected cells are shown, with the Hoechst fluores-
cence in blue.
Statistical analysis
Luciferase assays were performed in triplicate, with one
representative set shown in Figure 1. Values indicating the
mean +/- the standard error of the mean and compared
between assays for significance at p < 0.05 using the Stu-
dent t-test. Values obtained from counts of cells with
predominantly nuclear or predominantly cytoplasmic loca-
lization of various proteins were analyzed for differences
using a Fisher exact test.
Results
Expression of Magel2 reduces Clock:Bmal1 heterodimer
activity at the Per2 promoter
Modulation of circadian rhythm by Magel2 could
involve regulation of Clock:Bmal1-mediated transcrip-
tion, which can be measured by ectopic expression of
reporter constructs in tissue culture cells [38]. The
reporter plasmid (mPer2-E2:Luciferase,m P e r 2 : l u c )c o n -
taining a circadian E-box enhancer (E2) was activated
4.5-fold by Clock:Bmal1, as expected (Figure 1, assay 2
versus assay 1). Co-expression of either Cry1 or Per2
repressed Clock:Bmal1-mediated activation of mPer2:luc
Figure 1 Magel2 represses Clock:Bmal1-mediated transcription at an E-box promoter. Dual luciferase transcription assays following
transfection of NIH3T3 cells with the mPer2:luc reporter plasmid and a renilla internal control plasmid, together with combinations of expression
plasmids variously encoding epitope-tagged Clock, Bmal1, Magel2, Cry1, and Per2 proteins. Data are normalized to the baseline activity of the
normalized mPer2:luc reporter. A * indicates a significant difference from the baseline mPer2:luc activity, and a # indicates a significant repression
compared to Bmal1:Clock-mediated activation (p < 0.05). These results represent one of three experiments completed in triplicate. Error bars
represent the standard error of the mean.
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stronger repressor than Per2, decreased relative lucifer-
ase activity significantly below baseline (assay 1) levels,
likely because Cry1 is also inhibiting the activity of
endogenous Clock:Bmal1 on the mPer2:luc construct. In
turn, Magel2 also significantly repressed activation by
Clock:Bmal1 (assay 5 versus assay 2). Repression by
Magel2 was intermediate in strength between that of the
more repressive Cry1 and the less repressive Per2. These
results suggest that Magel2 can act as a negative regula-
tor of Clock/Bmal1-mediated transcription.
Magel2 interacts with Bmal1 and Per2
We next tested whether Magel2 interacts with Bmal1 or
Per2 by co-immunoprecipitating epitope-tagged proteins
in transfected HEK293 cells (Figure 2). Protein lysates
from cells co-transfected with pXpress-Magel2 and pHA-
B m a l 1w e r ei m m u n o b l o t t e dt oc o n f i r mt h ep r e s e n c eo f
both pXpress-Magel2 and pHA-Bmal1 in the appropriate
samples (Figure 2A). We immunoprecipitated the same
lysate with anti-HA antibodies (to immunoprecipitate
Bmal1), then immunoblotted with anti-Xpress to detect
Magel2. We only detected immunoprecipitated Xpress-
Magel2 in the sample with co-expressed HA-Bmal1, and
not in the sample transfected with empty vector control.
In the reciprocal experiment, immunoprecipitation of
Xpress-Magel2 also co-immunoprecipitated HA-Bmal1.
Likewise, we co-transfectedp X p r e s s - M a g e l 2a n dp V 5 -
Per2 into HEK293 cells, and detected interactions by co-
immunoprecipitation (Figure 2B). In this case, in an
immununoprecipitation with anti-V5, Xpress Magel2 was
only detected in the presence of co-expressed V5-Per2.
While we did detect V5-Per2 when we immunoprecipi-
tated Xpress-Magel2, there was also some immunopreci-
pitation of V5-Per2 in the absence of Xpress-Magel2,
which we interpret as nonspecific binding of V5-Per2 to
the protein G beads used in the assay.
The co-immunoprecipitation experiments show that
Magel2 can physically interact with Bmal1, and likely also
with Per2. We next examined whether Magel2 co-loca-
lized with either protein in transfected cells, by immuno-
fluorescence (Figure 3). We acquired fluorescence images
of co-transfected individual cells, using Hoechst staining
to visualize the nucleus. We then converted the images to
RGB stacks and plotted the fluorescence intensity in lines
drawn across individual cells. Fluorescence intensities
were acquired in three channels, plotted, and visually
examined for overlap in the profiles. The profile of Magel2
Figure 2 Magel2 interacts with Bmal1 and Per2. A) HEK293 cells were transfected with expression plasmids encoding HA-Bmal1, Xpress-
Magel2, or both constructs. Five percent of the volume of cell lysate used for immunoprecipitation was immunoblotted to confirm the presence
of HA-Bmal1 and Xpress-Magel2 protein in the appropriate input samples (top). The protein complexes were immunoprecipitated with anti-HA
or anti-Xpress antibodies, and the immunoprecipitates detected by immunoblotting with antibodies directed against the reciprocal epitope tag
(bottom). B) HEK293 cells were transfected with expression plasmids encoding V5-Per2, Xpress-Magel2, or both constructs. Five percent of the
volume of cell lysate used for immunoprecipitation was immunoblotted to confirm the presence of Xpress-Magel2 and V5-Per2 protein in the
appropriate input samples (top). The protein complexes were immunoprecipitated with anti-V5 or anti-Xpress antibodies, and the
immunoprecipitates detected by immunoblotting with antibodies directed against the reciprocal epitope tag (bottom).
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ping signals in the cytoplasm in most cells, but also in the
nucleus in some cells (e.g. right hand profile in Figure 3A,
Magel2/Clock). In about half the cells in which Magel2
and Bmal1 were co-expressed, the fluorescence overlapped
in the cytoplasm but overlap was not seen in the nucleus
(Figure 3B). We also detected overlapping profiles for
Magel2 and Per2, in both the nucleus and the cytoplasm,
in some but not all cells (Figure 3C). Lastly, there was no
evidence of overlapping profiles in cells co-transfected
with Magel2 and Cry1 (Figure 3D).
Subcellular localization of Bmal1 is altered on co-
expression of Magel2
Bmal1 is regulated by post-translational modifications
that alter its stability and subcellular localization. A pre-
vious study showed that Bmal1 is predominantly located
within the nucleus whether transfected alone or with
Clock [36]. We transfected NIH3T3 cells plated on cov-
erslips with various combinations of constructs encoding
either epitope-tagged circadian proteins or the empty
vector control plasmid, then detected the proteins by
immunofluorescence. The subcellular localization of each
protein was considered either nuclear or cytoplasmic
depending upon the subcellular region where the greatest
level of fluorescence was observed, in 100 cells for each
plasmid combination (Figure 4A). Consistent with pre-
vious results, myc-Clock was predominantly cytoplasmic
in most cells when expressed alone (Figure 4B, see also
Figure 3A), whereas HA-Bmal1 was predominantly
nuclear (Figure 4C, see also Figure 3B). Consistent with
the idea that the nuclear accumulation of Clock is
Bmal1-dependent, co-expression of Bmal1 in Clock-
transfected cells promoted the nuclear accumulation of
Clock (Figure 4B). In contrast, Magel2 significantly pro-
moted the cytoplasmic accumulation of Clock. However,
when Clock, Bmal1, and Magel2 were all co-expressed,
Clock was mostly nuclear, suggesting that Bmal1-induced
nuclear shuttling of Clock is more robust than the effect
of Magel2. The effect of Magel2 on the subcellular distri-
bution of Bmal1 was less striking: Magel2 induced a
redistribution of Bmal1 towards the cytoplasm, an effect
that was reversed by co-expression of Clock (Figure 4C).
These data suggests that Magel2 can influence the sub-
cellular localization of circadian rhythm proteins. As
these proteins are known to vary in their subcellular loca-
lization depending on circadian time [36], Magel2 may
have different activities depending on the relative abun-
dance of these proteins at different circadian times. In
contrast, we found no evidence that Magel2 influences
Figure 3 Subcellular localization of circadian proteins in the presence of Magel2. pXpressMagel2 and plasmids encoding other epitope-
tagged circadian proteins (A, Clock, B, Bmal1, C, Per2, and D, Cry1) were detected in co-transfected NIH3T3 cells by immunofluorescence. Plots
of fluorescence intensity were generated to assess overlap between the immunofluorescence signals from each protein within transfected cells,
which were also stained with Hoechst 33342 to label the nucleus.
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combinations of Xpress-Magel2 and circadian expression constructs. Transfected cells were scored as having the majority of the fluorescent
signal either in the nucleus or in the cytoplasm. Differences in the nuclear/cytoplasmic distribution between transfections were detected using a
Fisher exact test, with p < 0.05 deemed statistically significant. A) Example of primarily nuclear (N) or primarily cytoplasmic (C) localization of
epitope tagged Bmal1 (in green, nucleus is in blue). B) Localization of Clock when expressed alone (C), expressed with Bmal1 (CB), expressed
with Magel2 (CM) or expressed with Clock and Magel2 (CBM). C) Localization of Bmal1 when expressed alone (B), expressed with Clock (BC),
expressed with Magel2 (BM) or expressed with Clock and Magel2 (BCM).
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fected cells.
Stability of proteins in the presence of Magel2
MAGE proteins interact with RING-domain proteins asso-
ciated with E3 ligase complexes to modulate proteasomal
degradation of specific target proteins. We therefore tested
whether expression of varying amounts of Magel2 had any
effect on the abundance of co-expressed proteins with
which it can interact, including Bmal1 and Per2, in the
presence or absence of their heterodimerization partners
Clock (for Bmal1) or Cry1 (for Per2). We co-transfected
cells with increasing amount of pXpress-Magel2 and a
constant amount of pHA-Bmal1, keeping the total amount
of plasmid constant with the appropriate empty expression
construct backbone. We then immunoblotted separately
with anti-HA antibodies to detect Bmal1, and with anti-
Xpress antibodies to detect Magel2. We repeated this
experiment adding a constant amount of pmyc-Clock, to
determine whether any change in stability required the
presence of this heterodimerization partner. Similarly, we
co-transfected pXpress-Magel2 and pV5-Per2, with or
w i t h o u tp V 5 - C r y 1 ,a n dq u a n t i f i e dt h e s ep r o t e i n so n
immunoblots. We also performed experiments using the
protein synthesis inhibitor cycloheximide to measure the
half-life of these various circadian proteins in the presence
or absence of Magel2. We found no evidence for any influ-
ence of Magel2 on the stability or abundance of circadian
proteins in these co-transfection experiments (data not
shown).
Discussion
The mammalian circadian clock oscillates in a robust, self-
sufficient manner. At least two transcription/translation/
post-translation feedback loops defend the circadian cycle
against random perturbations, while allowing outside sti-
muli to entrain and tune the oscillator to adapt to environ-
mental changes. Mutations in circadian genes can lead to
mistiming of circadian rhythm, disrupting physiological
processes such as sleep, metabolism, and endocrine func-
tion. Magel2 has many properties that suggest that it mod-
ulates circadian rhythm: it is primarily expressed in the
suprachiasmatic nucleus where its transcription oscillates
in phase with clock-controlled genes, mice lacking Magel2
have disrupted circadian rhythm and metabolic and endo-
crine deficits, and other members of the Magel2 protein
family are directly or circumstantially implicated in circa-
dian rhythm through mouse knockout studies or physical
interactions with core circadian proteins. Notably, Magel2
is not expressed in peripheral tissues that maintain a circa-
dian cycle, such as the liver, so Magel2 is not required for
the cellular maintenance of circadian rhythm per se.M o r e -
over, Magel2 is not typically identified in screens that
depend on gene expression in more than one tissue (e.g.
SCN and liver) or that examine cell lines of non-neuronal
origin: Magel2 is not expressed in NIH3T3 or HEK293
cells (data not shown). In this study, we explored interac-
tions between Magel2 and the primary circadian feedback
loop, involving positive regulation by Clock:Bmal1 hetero-
dimers that initiate transcription of clock-controlled
genes, and negative regulation by Per:Cry heterodimers
that repress their own transcription by inhibiting Clock:
Bmal1-dependent transcription.
We examined several possible mechanisms for the
repressive effect of Magel2 on Clock:Bmal1 transcriptional
activation, focusing on interactions with circadian compo-
nents, and effects on sub-cellular localization and stability
of core circadian proteins. Consistent with a role as a
negative regulator of intrinsic circadian rhythm, Magel2
represses Clock:Bmal1-dependent transcription at a Per2
E-box promoter. In principal, Magel2 may act at the target
promoter, alter Clock or Bmal1 independent of promoter
binding, or modify the activity of another protein that
influences Clock:Bmal1 activity. Furthermore, the repres-
sive function could occur either in the nucleus or in the
cytoplasm, as the activity of proteins located in either sub-
cellular compartment can influence activation of clock-
controlled genes [36,37,39]. Moreover, the relative abun-
dance of circadian proteins and their subcellular location
depends on the circadian time. Between CT 6-10, Clock:
Bmal1 is most transcriptionally active in the SCN, with
the peak of expression of many clock controlled genes
occurring towards the end of this interval. Per2, Atp6a,
and Ccr4 transcription peaks around CT10, and Magel2 at
around CT14, preceding the expression of Bmal1 from
CT16-21 [6,11]. While Clock is constitutively expressed,
its endogenous subcellular localization undergoes a circa-
dian oscillation in the SCN [36]. Interestingly, Clock pro-
tein is mostly nuclear at CT13 and mostly cytoplasmic by
CT19, when Magel2 protein is expected to be most abun-
dant. Our observation that expressing Magel2 in Clock-
transfected cells increases the abundance of Clock in the
cytoplasm, and that Magel2 and Clock have overlapping
immunofluorescence profiles in the cytoplasm of co-trans-
fected cells suggests that Magel2 could be involved in
retaining or stabilizing Clock in the cytoplasm around
CT19. At this time, cytoplasmic Bmal1 protein levels
begin to rise, and Bmal1-mediated nuclear translocation of
Clock:Bmal1 complexes occurs. Consistent with this sce-
nario, expression of Magel2 in Clock:Bmal1 doubly-trans-
fected cells did not promote the accumulation of Clock in
the cytoplasm, presumably because Bmal1 is more
strongly promoting the nucleus-directed movement of
Clock. We also observed overlap in the fluorescence sig-
nals of Magel2 and Bmal1, and co-immunoprecipitated
Magel2 and Bmal1 in co-transfected cells. The transition
from Magel2-mediated cytoplasmic retention of Clock to
Bmal1-mediated nuclear translocation of Clock may thus
Devos et al. Journal of Circadian Rhythms 2011, 9:12
http://www.jcircadianrhythms.com/content/9/1/12
Page 8 of 10involve a physical association between Magel2 and Bmal1.
Thus, Magel2 could increase the robustness of the pro-
grammed delay in the feedback loop, by modulating
Clock:Bmal1 interactions in the cytoplasm prior to the
nuclear accumulation of the Clock:Bmal1 heterodimer.
Our co-immunoprecipitation experiments also detected
an interaction between Magel2 and Per2, and analysis of
immunofluorescence images of Magel2:Per2 co-trans-
fected cells revealed overlap in the immunofluorescence
signals in some, but not all cells. The transcription of Per2
occurs from around CT10, but the repressive activity of
the Per:Cry heterodimer in the nucleus is delayed by the
activities of F-box associated E3 ubiquitin ligases that reg-
ulate the transient accumulation of Cry and Per proteins
in the cytoplasm, forming a rate-limiting step in the circa-
dian feedback loop [40]. Indeed, mutations in the genes
encoding subunits of these phosphorylation and degrada-
tion complexes cause circadian defects in mice [14,41].
MAGE proteins are adaptors for E3 ubiquitin ligase com-
plexes, but the activity of Magel2 in these complexes
remains enigmatic. The interaction of Magel2 with Per2
may add robustness to the negative limb of the feedback
loop through interactions that promote transient Per2
retention or stability in the cytoplasm. However, we did
not see a Magel2-dependent accumulation of Per2 in the
cytoplasm, and expression of Magel2 does not alter the
stability of Per2, arguing against this role for Magel2 in
the cytoplasm. Future studies that examine interactions of
Magel2 with RING proteins implicated in the degradation
of circadian proteins may shed further light on this pro-
cess. Alternatively, Magel2 could interact with Per2 while
it inhibits Clock:Bmal1 in the nucleus, as we did observe
overlap of the Magel2 and Per2 immunofluorescence sig-
nals in the nucleus in co-transfected cells. Other possible
relationships between Magel2 and circadian proteins have
not yet been explored. The MAGE protein necdin regu-
lates the acetylation status and activity of p53 through
interactions with SIRT1, and the acetylation and activity of
Per2 is also modulated by SIRT1, and Magel2 could take
part in this regulation. Another MAGE protein, Maged1,
acts in a second auto-regulatory loop involving the Clock:
Bmal1 activated transcription of retinoic acid-related
orphan nuclear receptors Rev-erba and Rora., by coop-
erating with Rora to modulate the expression of circadian
genes, including Bmal1 and Rev-erba [34] through
response elements in their promoters, but a parallel role
for Magel2 has not been explored.
Although a small handful of extensively studied proteins
drive core circadian rhythm feedback loops, hundreds of
additional proteins control the robustness of this rhythm
to compensate for external influences [42]. It has proven
challenging to integrate these novel components into the
molecular circuitry that drives the rhythm, particularly for
proteins whose function is poorly understood. As Magel2
is not expressed in the mouse liver, mouse embryonic
fibroblasts, or in many cultured cell lines typically used for
studies of circadian proteins, our study was limited to the
examination of heterologously expressed epitope-tagged
proteins. Further molecular characterization of Magel2 in
circadian pathways, and continued analysis of circadian
defects in the Magel2-null mouse strain will elucidate the
contribution of this enigmatic protein to mammalian cir-
cadian rhythm. In particular, it will be important to deter-
mine whether Magel2 co-localizes with circadian proteins
in SCN neurons, and whether the loss of the endogenous
Magel2 protein affects the activity of the Clock:Per2 het-
erodimer in SCN neurons, to elucidate the role of Magel2
in the intrinsic circadian rhythm versus its potential devel-
opmental role in the hypothalamus. These studies will also
add to our understanding of the role of normal circadian
rhythm in human health, and the etiology of circadian
rhythm dysfunction in human genetic disorders such as
Prader-Willi syndrome.
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